Prognostic impact of the timing of immunotherapy in first‐line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score‐matched analysis

Documenti analoghi

• Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study
  di: Yihui Ge, et al.
  Pubblicazione: (2024)
• ILT4 facilitates angiogenesis in non‐small cell lung cancer
  di: Shuyun Wang, et al.
  Pubblicazione: (2024)
• Impact of sarcopenia on the prognosis of patients with advanced non‐small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis
  di: Fuchun Huang, et al.
  Pubblicazione: (2024)
• A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations
  di: Li Wang, et al.
  Pubblicazione: (2024)
• Efficacy of postoperative immunotherapy on MPM patients after CRS + HIPEC: A single‐center retrospective study based on propensity score matching
  di: Xin‐Li Liang, et al.
  Pubblicazione: (2025)